Add-on Acquisition • Medical Products

Allergan Acquires Forest Laboratories

On February 18, 2014, Allergan acquired medical products company Forest Laboratories for 25.0B USD

Acquisition Context
  • This is Allergan’s 3rd transaction in the Medical Products sector.
  • This is Allergan’s 2nd largest (disclosed) transaction.
  • This is Allergan’s 8th transaction in the United States.
  • This is Allergan’s 1st transaction in New York.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free


M&A Deal Summary

Date February 18, 2014
Target Forest Laboratories
Sector Medical Products
Buyer(s) Allergan
Deal Type Add-on Acquisition
Deal Value 25.0B USD
Advisor(s) J.P. Morgan Securities (Financial)
Wachtell, Lipton, Rosen & Katz (Legal)

Target Company

Forest Laboratories

New York, New York, United States
Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Allergan

Parsippany, New Jersey, United States

Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.


Deal Context for Buyer #
Overall 14 of 38
Sector: Medical Products 3 of 11
Type: Add-on Acquisition 11 of 31
State: New York 1 of 2
Country: United States 8 of 27
Year: 2014 1 of 5
Size (of disclosed) 2 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-06 Palau Pharma - Albaconazole Antifungal Agent

United States

Palau Pharma - Albaconazole Antifungal Agent an oral antifungal agent for the treatment of vulvo-vaginal candidiasis, onychomycosis and other antifungal applications.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-04-01 Silommedical Co.

Bangkok, Thailand

Silommedical Co., Ltd. is a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand

Buy $100M